HK1245664B - 用於治療與皮脂分泌過多有關的皮膚問題的多肽 - Google Patents
用於治療與皮脂分泌過多有關的皮膚問題的多肽Info
- Publication number
- HK1245664B HK1245664B HK18105412.9A HK18105412A HK1245664B HK 1245664 B HK1245664 B HK 1245664B HK 18105412 A HK18105412 A HK 18105412A HK 1245664 B HK1245664 B HK 1245664B
- Authority
- HK
- Hong Kong
- Prior art keywords
- overproduction
- sebum
- polypeptides
- conditions associated
- skin conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Marine Sciences & Fisheries (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562168374P | 2015-05-29 | 2015-05-29 | |
PCT/CA2016/050605 WO2016191864A1 (en) | 2015-05-29 | 2016-05-27 | Polypeptides and antibodies to treat skin conditions associated with overproduction of sebum |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1245664B true HK1245664B (zh) | 2020-06-26 |
Family
ID=57439738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18105412.9A HK1245664B (zh) | 2015-05-29 | 2018-04-25 | 用於治療與皮脂分泌過多有關的皮膚問題的多肽 |
Country Status (7)
Country | Link |
---|---|
US (1) | US11117939B2 (zh) |
EP (1) | EP3307317B1 (zh) |
JP (1) | JP6853239B2 (zh) |
KR (1) | KR20180012833A (zh) |
CN (1) | CN107921125B (zh) |
HK (1) | HK1245664B (zh) |
WO (1) | WO2016191864A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107325157B (zh) * | 2017-08-07 | 2020-06-26 | 温州千瑞生物科技有限公司 | 调节皮脂分泌的肽以及包含其的化妆品 |
KR102268921B1 (ko) * | 2019-12-10 | 2021-06-23 | 강원대학교산학협력단 | p53을 활성화하는 펩타이드를 포함하는 조성물 |
KR102084163B1 (ko) * | 2019-12-27 | 2020-05-15 | 주식회사 인투앱 | 프로피오니박테리움 아크네스 균으로부터 유래한 지방산 분해 효소에 특이적으로 결합하는 신규한 항체 및 이의 용도 |
EP4215178A1 (en) | 2020-09-11 | 2023-07-26 | Chemyunion Ltda | Composition, use of the composition, cosmetic method and method for modulating the production of sebum |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007289063A (ja) * | 2006-04-25 | 2007-11-08 | Shiseido Co Ltd | しみ部位亢進遺伝子群を指標とした皮膚しみ形成予知方法、皮膚しみ形成抑制剤のスクリーニング方法 |
CN101674730B (zh) * | 2007-02-02 | 2014-09-10 | 贝勒医学院 | 用于治疗代谢疾病的组合物和方法 |
WO2009121176A1 (en) * | 2008-03-31 | 2009-10-08 | The University Of British Columbia | Insulin-induced gene (insig) peptide compositions and methods for cytoprotection |
RU2011138183A (ru) * | 2009-02-24 | 2013-04-10 | Хилор Лтд. | Висфатиновые терапевтические средства для лечения акне и других состояний |
JP2011225455A (ja) * | 2010-04-15 | 2011-11-10 | Kao Corp | Srebp抑制剤 |
JP5353848B2 (ja) * | 2010-09-24 | 2013-11-27 | 株式会社アドヴィックス | 車両用ブレーキ装置 |
RU2014119426A (ru) * | 2011-10-15 | 2015-11-20 | Дженентек, Инк. | Способы применения антагонистов scd1 |
KR101528770B1 (ko) * | 2013-06-13 | 2015-06-15 | 코스맥스 주식회사 | 사과 유래 폴리페놀을 함유하는 피지분비 완화 및 여드름 증상 개선용 화장료 조성물 |
-
2016
- 2016-05-27 CN CN201680039396.8A patent/CN107921125B/zh active Active
- 2016-05-27 JP JP2018513701A patent/JP6853239B2/ja active Active
- 2016-05-27 US US15/576,747 patent/US11117939B2/en active Active
- 2016-05-27 WO PCT/CA2016/050605 patent/WO2016191864A1/en active Application Filing
- 2016-05-27 EP EP16802284.6A patent/EP3307317B1/en active Active
- 2016-05-27 KR KR1020177037904A patent/KR20180012833A/ko not_active Application Discontinuation
-
2018
- 2018-04-25 HK HK18105412.9A patent/HK1245664B/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP6853239B2 (ja) | 2021-03-31 |
WO2016191864A1 (en) | 2016-12-08 |
EP3307317A1 (en) | 2018-04-18 |
US11117939B2 (en) | 2021-09-14 |
JP2018517767A (ja) | 2018-07-05 |
US20180305419A1 (en) | 2018-10-25 |
KR20180012833A (ko) | 2018-02-06 |
CN107921125A (zh) | 2018-04-17 |
EP3307317B1 (en) | 2019-09-04 |
CN107921125B (zh) | 2021-06-08 |
EP3307317A4 (en) | 2019-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286888A (en) | Use of pyridofidine to treat depression and anxiety | |
PL3349783T3 (pl) | Kompozycje i sposoby do leczenia chorób | |
HK1246179A1 (zh) | 治療視網膜疾病的方法 | |
PL3244819T3 (pl) | Urządzenie do kosmetycznego leczenia brązowych plam skóry za pomocą kriogeniki | |
HUE054828T2 (hu) | Eljárások és készítmények a bél enteroendokrin rendszerének stimulálására a vele kapcsolatos betegségek és állapotok kezelésére | |
GB201404403D0 (en) | Compositions and methods relating to the treatment of diseases | |
HK1245664B (zh) | 用於治療與皮脂分泌過多有關的皮膚問題的多肽 | |
HK1243719A1 (zh) | 用以治療血管新生相關疾病和/或症狀的短合成肽 | |
GB201611413D0 (en) | Method of skin care | |
IL259781A (en) | Uses of pyrimido-pyridazinones to treat cancer | |
HK1247884A1 (zh) | 用於皮膚的美容處理的方法 | |
PT3393517T (pt) | Ácido acetilsalicílico para utilização no tratamento de influenza moderada a grave | |
SG11201704086WA (en) | Cosmetic use of heparan sulphate | |
HK1243937A1 (zh) | 治療疾病的方法 | |
EP3271017A4 (en) | Treatment of skin conditions | |
HUE062134T2 (hu) | Mitokondriális betegségek kezelése | |
HK1256840A1 (zh) | 含有蛋白的外用皮膚組合物和使用方法 | |
EP3534932C0 (en) | TREATMENT OF DISEASES RELATED TO IGFB3 AND ITS RECEPTOR | |
AU2015900943A0 (en) | Treatment of skin conditions | |
HK1214075A2 (zh) | 符合人體曲線的修身打底褲 | |
GB201516303D0 (en) | Compositions and methods relating to the treatment of diseases | |
GB201514909D0 (en) | Treatment of autoimmune diseases | |
ZA201504639B (en) | Treatment of water | |
GB201414023D0 (en) | Treatment of autoimmune diseases | |
AP2016009662A0 (en) | Combination of taurine and racemethionine for treatment of liver diseases |